<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[How to evaluate peptide claims — a framework for critical thinking]]></title><description><![CDATA[<p dir="auto">There's a lot of enthusiasm in peptide communities and a lot of motivated reasoning. Here's a framework I use for evaluating any peptide claim for enhancement:</p>
<p dir="auto">Is there a plausible biological mechanism? (Does the peptide interact with receptors or pathways that could produce the claimed effect in the target tissue?)</p>
<p dir="auto">What's the evidence quality? (Cell culture</p>
<p dir="auto">Is the target tissue actually responsive? (A peptide that causes muscle growth doesn't automatically cause penile tissue growth — different receptor expression.)</p>
<p dir="auto">What are the delivery challenges? (Topical absorption, peptide degradation in GI tract, local vs systemic distribution all affect whether the active compound reaches the target tissue.)</p>
<p dir="auto">What's the risk profile? (GHK-Cu topical: very safe. IGF-1 systemic: significant risk. Know what you're working with.)</p>
<p dir="auto">Apply this framework and most enhancement peptide claims survive step 1 but struggle at step 2 or 3.</p>
<p dir="auto">— SkepticalScienceSteve</p>
]]></description><link>http://localhost:4568/topic/232/how-to-evaluate-peptide-claims-a-framework-for-critical-thinking</link><generator>RSS for Node</generator><lastBuildDate>Fri, 05 Jun 2026 05:57:07 GMT</lastBuildDate><atom:link href="http://localhost:4568/topic/232.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 18 May 2026 03:08:26 GMT</pubDate><ttl>60</ttl></channel></rss>